Bioasis Technologies Inc. (BIOAF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | -3.63 Million | 1.77 Million | -3.29 Million | -3.22 Million | -3.67 Million |
| Net Income | - | -2.96 Million | 698.41 Thousand | -4.05 Million | -3.47 Million | -5.3 Million |
| Depreciation & Amortization | - | 54.91 Thousand | 60.48 Thousand | 70.77 Thousand | 71.99 Thousand | 58.88 Thousand |
| Deferred income taxes | - | -1.42 Million | 871.9 Thousand | -624.39 Thousand | - | - |
| Stock-based compensation | - | 440.58 Thousand | 278.99 Thousand | 565.55 Thousand | 980.19 Thousand | 1.47 Million |
| Change in working capital | - | -401.7 Thousand | -247.52 Thousand | 691.52 Thousand | 568.37 Thousand | 101.77 Thousand |
| Other non-cash items | - | 654.51 Thousand | 109.21 Thousand | 54.31 Thousand | -1.37 Million | 1.35 Million |
| Investing Cash Flow | - | - | 6967.00 | - | 393 Thousand | -107.71 Thousand |
| Investments in PPE | - | - | - | - | -2062.00 | -107.71 Thousand |
| Acquisitions | - | - | 6967.00 | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 6967.00 | - | 395.07 Thousand | - |
| Financing Cash Flow | - | 2.63 Million | 312.38 Thousand | 2.49 Million | 3.52 Million | 3.9 Million |
| Debt repayment | - | -375 Thousand | -696.15 Thousand | -1.28 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 196.03 Thousand | 192.19 Thousand | 1.2 Million | 3.52 Million | 3.9 Million |
| Other Financing Activities | - | 2.81 Million | 816.34 Thousand | 2.57 Million | - | - |
| Accounts receivables | - | -67.03 Thousand | -16.9 Thousand | -3658.00 | 24.02 Thousand | 24.22 Thousand |
| Accounts payables | - | -513.02 Thousand | 12.18 Thousand | 1 Million | 210.88 Thousand | 213.79 Thousand |
| Inventory | - | 513.02 Thousand | -12.18 Thousand | -1 Million | -234.9 Thousand | - |
| Other working capital | - | -334.66 Thousand | -230.62 Thousand | 691.52 Thousand | 568.37 Thousand | 101.77 Thousand |
| Cash at beginning of period | 1.73 Million | 2.73 Million | 576.37 Thousand | 1.36 Million | 677.97 Thousand | 554.28 Thousand |
| Cash at end of period | 1.73 Million | 1.73 Million | 2.73 Million | 576.37 Thousand | 1.36 Million | 677.97 Thousand |
| Capital Expenditure | - | - | - | - | -2062.00 | -107.71 Thousand |
| Effect of forex changes on cash | - | -6076.00 | 69.53 Thousand | 22.17 Thousand | -7928.00 | - |
| Net cash flow / Change in cash | - | -1 Million | 2.16 Million | -783.67 Thousand | 682.07 Thousand | 123.68 Thousand |
| Free Cash Flow | - | -3.63 Million | 1.77 Million | -3.29 Million | -3.23 Million | -3.78 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | - | -985.67 Thousand | -1.09 Million |
| Depreciation & Amortization | - | - | - | - | 34.83 Thousand | 31.32 Thousand |
| Deferred income taxes | - | - | - | - | 57.35 Thousand | -50.09 Thousand |
| Stock-based compensation | - | - | - | - | 3824.00 | 251 Thousand |
| Change in working capital | - | - | - | - | 236.43 Thousand | 403.95 Thousand |
| Other non-cash items | - | - | - | - | 209.92 Thousand | 230.31 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | 4952.00 | 156.83 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | 231.48 Thousand | 247.11 Thousand |
| Cash at beginning of period | - | - | 1.73 Million | 156.51 Thousand | 568.22 Thousand | 764.96 Thousand |
| Cash at end of period | - | - | 1.73 Million | 156.51 Thousand | 156.51 Thousand | 568.22 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | 31.59 Thousand | 26.94 Thousand |
| Net cash flow / Change in cash | - | - | - | - | -411.71 Thousand | -196.74 Thousand |
| Free Cash Flow | - | - | - | - | -443.3 Thousand | -223.68 Thousand |
XOM
CEGMF
010120
9271
MPOW
AMPY